We are live on ! Find out more
DOA

D'Orazio & Associates Portfolio holdings

AUM $864M
1-Year Est. Return 21.64%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+21.64%
3 Year Est. Return
+61.22%
5 Year Est. Return
+65.95%
10 Year Est. Return
+224.42%
AUM
$285M
AUM Growth
+$14.8M
Cap. Flow
+$5.19M
Cap. Flow %
1.82%
Top 10 Hldgs %
87%
Holding
356
New
64
Increased
80
Reduced
39
Closed
23

Sector Composition

Rank Sector Weight
1 Industrials 14.88%
2 Financials 9.34%
3 Healthcare 4.66%
4 Consumer Discretionary 1.22%
5 Technology 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUG icon
301
Plug Power
PLUG
$2.87B
$2K ﹤0.01%
1,000
SCHD icon
302
Schwab US Dividend Equity ETF
SCHD
$103B
$2K ﹤0.01%
+114
New +$1.87K
SIRI icon
303
SiriusXM
SIRI
$9.98B
$2K ﹤0.01%
40
STNG icon
304
Scorpio Tankers
STNG
$3.9B
$2K ﹤0.01%
50
TPVG icon
305
TriplePoint Venture Growth BDC
TPVG
$184M
$2K ﹤0.01%
173
+4
+2% +$54
VUZI icon
306
Vuzix
VUZI
$194M
$2K ﹤0.01%
+340
New +$1.97K
WKHS icon
307
Workhorse Group
WKHS
$33.2M
0
VGR
308
DELISTED
Vector Group Ltd.
VGR
$2K ﹤0.01%
163
ZN
309
DELISTED
Zion Oil & Gas, Inc.
ZN
$2K ﹤0.01%
1,150
AGN
310
DELISTED
Allergan plc
AGN
$2K ﹤0.01%
+14
New +$2.51K
COTY icon
311
Coty
COTY
$2.42B
$1K ﹤0.01%
42
FRO icon
312
Frontline
FRO
$8.76B
$1K ﹤0.01%
250
MSTR icon
313
Strategy Inc
MSTR
$34.1B
$1K ﹤0.01%
90
-430
-83% -$5.77K
TTNP
314
DELISTED
Titan Pharmaceuticals
TTNP
0
URA icon
315
Global X Uranium ETF
URA
$5.42B
$1K ﹤0.01%
70
VIAV icon
316
Viavi Solutions
VIAV
$9.12B
$1K ﹤0.01%
72
XPO icon
317
XPO
XPO
$23.5B
$1K ﹤0.01%
+17
New +$435
SYRS
318
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1K ﹤0.01%
+10
New +$1.34K
AIG.WS
319
DELISTED
American International Group, Inc.
AIG.WS
$1K ﹤0.01%
58
SCG
320
DELISTED
Scana
SCG
$1K ﹤0.01%
+23
New +$1.03K
WPG
321
DELISTED
Washington Prime Group Inc.
WPG
$1K ﹤0.01%
17
ARLZ
322
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$1K ﹤0.01%
1,006
ACHV icon
323
Achieve Life Sciences
ACHV
$659M
0
CNDT icon
324
Conduent
CNDT
$244M
-500
Closed -$8K
BGMS
325
Bio Green Med Solution Inc
BGMS
$4.91M
0

Similar funds

D'Orazio & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, D'Orazio & Associates held 356 positions worth $285M, up 5.5% from $270M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

D'Orazio & Associates's Q4 2017 filing shows 64 new, 80 increased, 39 reduced and 23 closed positions. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 19,170 shares worth $1.94M. The largest sale was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $1.45M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • D'Orazio & Associates's largest Q4 2017 buy was Invesco S&P 500 Equal Weight ETF: 19,170 shares worth $1.94M.
  • D'Orazio & Associates added most to Booz Allen Hamilton in Q4 2017, an estimated $5.83M increase.
  • D'Orazio & Associates's biggest Q4 2017 reduction was State Street SPDR Bloomberg Short Term High Yield Bond ETF, cutting an estimated $1.45M.
  • D'Orazio & Associates fully exited FBL Financial Group in Q4 2017, selling an estimated $103K.
  • D'Orazio & Associates's ten largest holdings make up 87% of its $285M portfolio in Q4 2017.
  • D'Orazio & Associates opened 64 new positions and closed 23 in Q4 2017.
  • D'Orazio & Associates's portfolio value rose 5.5% quarter-over-quarter to $285M.

Based on D'Orazio & Associates's 13F filing for Q4 2017, filed 6 Feb 2018.